Scott Morrison W.'s most recent trade in Zai Lab Limited - ADR was a trade of 21,253 American Depositary Shares done . Disclosure was reported to the exchange on June 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zai Lab Ltd (ADR) | Scott W. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 21,253 | 47,501 (0%) | 0% | 0 | American Depositary Shares | |
| Corvus Pharma Inc | Scott W. Morrison | Director | 13 Jun 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | ||
| Ideaya Biosciences Inc | Scott W. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 16,200 | 16,200 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | Scott W. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Corvus Pharma Inc | Scott Morrison W. | Director | 06 Dec 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | ||
| Corvus Pharma Inc | Scott W. Morrison | Director | 15 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | ||
| Ideaya Biosciences Inc | Scott W. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 16,200 | 16,200 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | Scott W. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |